Evidence-based medicine targets the individual patient, part 2: guides and tools for individual decision-making
| Autor: | Gordon H. Guyatt, Dirk Bassler, Paul J. Karanicolas, Jason W. Busse |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
medicine.medical_specialty
Physician-Patient Relations Evidence-Based Medicine business.industry Decision Making Alternative medicine General Medicine Evidence-based medicine Patient care law.invention Clinical trial Randomized controlled trial law medicine Humans Treatment effect Patient Care Patient Participation Adverse effect business Intensive care medicine Randomized Controlled Trials as Topic |
| Zdroj: | Evidence-based medicine. 13(5) |
| ISSN: | 1473-6810 |
| Popis: | Despite some suggestions to the contrary,1 2 evidence-based decision-making puts the individual patient on centre stage. In part 1 of this commentary,3 we first described the range of issues that clinicians should consider when applying randomised controlled trial (RCT) results to ensure appropriately individualised care (figure). Second, we have shown how clinicians can use results of prognostic studies and RCTs to determine each patient’s risk of the adverse events that treatment is designed to prevent, and thus each patient’s likely absolute benefit.3 In part 2 of this commentary we will describe additional evidence-based medicine (EBM) guides and tools that advance individual decision-making. Even if the overall relative summary treatment effect reported in a clinical trial suggests benefit, there may be … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|